COVID – 19 | Vaccination Update – Day 470

ad
Covid-19 coronavirus vaccine vial with syringe and stethoscope
Covid-19 coronavirus vaccine vial with syringe and stethoscope

India’s COVID-19 vaccination coverage has crossed 189 Crore landmark milestone (189,14,62,594today. More than 23 lakh (23,27,495) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10405238
2nd Dose 10017696
Precaution Dose 4819276
FLWs 1st Dose 18415940
2nd Dose 17541797
Precaution Dose 7650602
Age Group 12-14 years 1st Dose 29048728
2nd Dose 7318870
Age Group 15-18 years 1st Dose 58482238
2nd Dose 42398847
Age Group 18-44 years 1st Dose 555776423
2nd Dose 478685346
Precaution Dose 171840
Age Group 45-59 years 1st Dose 202932536
2nd Dose 188100114
Precaution Dose 575808
Over 60 years 1st Dose 126874441
2nd Dose 117196464
Precaution Dose 15050390
Cumulative 1st dose administered 1001935544
Cumulative 2nd dose administered 861259134
Precaution Dose 28267916
Total 1891462594

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 30th April, 2022 (470th Day)
HCWs 1st Dose 113
2nd Dose 1121
Precaution Dose 23498
FLWs 1st Dose 224
2nd Dose 2359
Precaution Dose 56941
Age Group 12-14 years 1st Dose 322683
2nd Dose 687607
Age Group 15-18 years 1st Dose 51935
2nd Dose 146723
Age Group 18-44 years 1st Dose 59575
2nd Dose 523721
Precaution Dose 23513
Age Group 45-59 years 1st Dose 13593
2nd Dose 141699
Precaution Dose 55052
Over 60 years 1st Dose 9891
2nd Dose 92649
Precaution Dose 114598
Cumulative 1st dose administered 458014
Cumulative 2nd dose administered 1595879
Precaution Dose 273602
Total 2327495

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply